FDA's Letter to Heron Therapeutics (HRTX) Over Sustol Approval

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 9/11/2026

1. COO
2. ORCL
3. CHWY
4. AVAV
5. ADBE

6. NVDA
7. MSFT
8. SPY
9. ASO
10. AAPL

August 10, 2016 12:50 PM EDT

Price: $0.32 -3.03%

Overall Analyst Rating:
SELL (= Flat)

EPS Growth %: +90.0%

Below is the FDA's approval letter Heron Therapeutics' (Nasdaq: HRTX) SUSTOL:

FDA, Insiders' Blog

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!